Nurse Prescribers 6th Edition Test Bank |
Chapters 1–57 Verified Q&A | Latest 2024
Edition
PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE NURSE
PRESCRIBERS — 6TH EDITION
Chapters 1–57 | | Latest 2024 Edition
CHAPTER HIGHLIGHTS
• Chapter 1 – The Role of the Nurse Practitioner as Prescriber
• Chapter 2 – Review of Basic Principles of Pharmacology
• Chapter 3 – Rational Drug Selection
• Chapter 4 – Legal and Professional Issues in Prescribing
• Chapter 5 – Adverse Drug Reactions
• Chapter 6 – Factors That Foster Positive Outcomes
• Chapter 7 – Cultural and Ethnic Influences in Pharmacotherapeutics
• Chapter 8 – Pharmacogenomics
• Chapter 9 – Pediatric Pharmacology
• Chapter 10 – Geriatric Pharmacology
• Chapter 11 – Women as Patients
• Chapter 12 – Drugs in Pregnancy
• Chapter 13 – Drugs in Lactation
• Chapter 14 – Nutritional Supplements
• Chapter 15 – Herbal Therapy and Nutritional Supplements
• Chapter 16 – Drug Interactions
• Chapter 17 – Drugs Affecting the Autonomic Nervous System
• Chapter 18 – Drugs Affecting the Central Nervous System
• Chapter 19 – Drugs Affecting the Cardiovascular System
,• Chapter 20 – Drugs Affecting Lipid Levels
• Chapter 21 – Drugs Affecting the Hematopoietic System
• Chapter 22 – Drugs Affecting the Immune System
• Chapter 23 – Drugs Used in Treating Infectious Diseases
• Chapter 24 – Drugs Used in Treating Inflammatory Processes
• Chapter 25 – Drugs Used in Treating Eye and Ear Disorders
• Chapter 26 – Drugs Affecting the Gastrointestinal System
• Chapter 27 – Drugs Affecting the Renal and Genitourinary Systems
• Chapter 28 – Drugs Affecting the Reproductive System
• Chapter 29 – Drugs Affecting the Integumentary System
• Chapter 30 – Drugs Used in Treating Respiratory System Disorders
• Chapter 31 – Drugs Used in Treating Endocrine System Disorders
• Chapter 32 – Drugs Used in Treating Musculoskeletal System Disorders
• Chapter 33 – Pain Management
• Chapter 34 – Headaches
• Chapter 35 – Anxiety and Depression
• Chapter 36 – Attention Deficit-Hyperactivity Disorder
• Chapter 37 – Altered Thought Processes
• Chapter 38 – Alzheimer's Disease
• Chapter 39 – Seizure Disorders
• Chapter 40 – Chronic Stable Angina and Low-Risk Unstable Angina
• Chapter 41 – Heart Failure
• Chapter 42 – Hyperlipidemia
• Chapter 43 – Hypertension
• Chapter 44 – Peripheral Neuropathy
• Chapter 45 – Sexually Transmitted Infections
• Chapter 46 – Upper Respiratory Infections
, • Chapter 47 – Lower Respiratory Infections
• Chapter 48 – Asthma and Chronic Obstructive Pulmonary Disease
• Chapter 49 – Rhinitis
• Chapter 50 – Peptic Ulcer Disease
• Chapter 51 – Gastroesophageal Reflux Disease
• Chapter 52 – Constipation, Diarrhea, and Irritable Bowel Syndrome
• Chapter 53 – Urinary Tract Infections
• Chapter 54 – Diabetes Mellitus
• Chapter 55 – Thyroid Disorders
• Chapter 56 – Anemia
• Chapter 57 – Hormone Replacement Therapy and Menopause Management
═══════════════════════════════════
CHAPTER 1 — The Role of the Nurse Practitioner as Prescriber
═══════════════════════════════════
QUESTION 1 Which of the following best describes the primary role of the nurse
practitioner (NP) as a prescriber?
A. To prescribe medications only under the direct supervision of a physician
B. To independently assess, diagnose, and manage patient conditions including
prescribing medications
C. To serve as a liaison between the pharmacist and the physician
D. To administer medications prescribed by a physician
E. To consult on medication management without prescriptive authority
CORRECT ANSWER: B. To independently assess, diagnose, and manage
patient conditions including prescribing medications
, RATIONALE: The NP role as a prescriber encompasses full assessment,
diagnosis, and therapeutic management of patient conditions including prescribing,
which is a hallmark of advanced practice nursing. The scope of this practice varies by
state but is increasingly moving toward full practice authority.
QUESTION 2 A nurse practitioner is reviewing prescribing laws in her state. Which
regulatory body primarily governs NP prescriptive authority at the state level?
A. The Drug Enforcement Administration (DEA)
B. The Food and Drug Administration (FDA)
C. The State Board of Nursing
D. The American Association of Nurse Practitioners (AANP)
E. The Centers for Medicare and Medicaid Services (CMS)
CORRECT ANSWER: C. The State Board of Nursing
RATIONALE: Prescriptive authority for nurse practitioners is governed at the state
level by the State Board of Nursing (and in some states jointly with the Board of
Medicine). The DEA regulates controlled substances at a federal level, and the FDA
regulates drug approval, but neither governs NP scope of practice.
QUESTION 3 Which of the following statements is TRUE regarding full practice
authority for nurse practitioners?
A. All 50 states grant NPs full practice authority
B. Full practice authority means NPs can practice and prescribe independently
without physician oversight
C. Full practice authority only applies to NPs in hospital settings
D. Full practice authority prohibits NPs from prescribing Schedule II controlled
substances
E. Full practice authority is federally mandated for all NPs
CORRECT ANSWER: B. Full practice authority means NPs can practice and
prescribe independently without physician oversight